Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Orthocell welcomes globally recognised nerve surgeons to advisory board

Orthocell welcomes globally recognised nerve surgeons to advisory board

Orthocell Ltd (ASX:OCC) MD Paul Anderson tells Proactive the company has appointed two internationally recognised orthopaedic surgeons specialising in nerve transfer and peripheral nerve repair, Professor Christopher Dy and Professor David Brogan, to the company’s Medical Scientific Advisory Board (MSAB). Professors Dy and Brogan are based at Washington University and Barnes-Jewish Orthopedic Center, one of the US’s leading academic research institutions and hospitals, and have been appointed to assist with clinical development and US market access for Orthocell’s nerve repair medical device.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK